Physician profile
Rizwan Jafri
NPI 1386930667
$7,166.27
in general payments reported to CMS, 2019-2025
25 companies · $646 in 2025
The $646 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,284 · 2020: $297 · 2021: $348 · 2022: $3,438 · 2023: $607 · 2024: $547 · 2025: $646.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,799.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,799.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,349.75 | 2019-2025 | Overstitch Endoscopic Suturing System, Overstitch Nxt Endoscopic Suturing System, Wallflex Duodenal |
| Ambu INC. | $624.30 | 2020-2022 | |
| Olympus America INC. | $501.18 | 2022-2025 | Visiglide, Single Use Aspiration Needle Na-U200h, Single Use Biopsy Valve (Sterile) |
| Medtronic, INC. | $331.10 | 2022 | |
| Merit Medical Systems INC | $309.35 | 2025 | Esophyx, Elation Balloon Dilator, Esophageal Stent/Delivery System |
| Takeda Pharmaceuticals U.S.A., INC. | $292.01 | 2019-2025 | Entyvio |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $277.48 | 2022-2023 | Xifaxan, Trulance |
| Endogastric Solutions, INC | $229.16 | 2023-2024 | Esophyx |
| Genzyme Corporation | $226.36 | 2022-2023 | |
| Abbvie INC. | $124.23 | 2019-2023 | |
| Apollo Endosurgery US INC | $124.18 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $123.83 | 2022 | |
| Micro-Tech Endoscopy USA, INC. | $117.14 | 2020 | |
| Celgene Corporation | $108.55 | 2022-2023 | Zeposia |
| Histosonics, INC. | $96.57 | 2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intra-Sana Laboratories | $54.77 | 2021-2022 | |
| Wilson Cook Medical Incorporated | $53.83 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $49.72 | 2023 | Dupixent |
| Nestle Healthcare Nutrition INC. | $47.91 | 2022-2023 | |
| Alfasigma USA, INC. | $31.08 | 2021-2022 | |
| Lucid Diagnostics INC. | $20.92 | 2022 | |
| Merck Sharp & Dohme LLC | $19.96 | 2021 | |
| Ardelyx, INC. | $19.07 | 2022 | |
| Ferring Pharmaceuticals INC. | $18.03 | 2022 | |
| Janssen Biotech, INC. | $15.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rizwan Jafri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.